Last $1.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
BOPH On Other Exchanges
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

bohai pharmaceuticals group (BOPH) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/15/14 - $1.05
52 Week Low
12/11/13 - $0.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

bohai pharmaceuticals group (BOPH) Related Businessweek News

No Related Businessweek News Found

bohai pharmaceuticals group (BOPH) Details

Bohai Pharmaceuticals Group, Inc., through its subsidiaries, produces, manufactures, and distributes herbal pharmaceuticals based on traditional Chinese medicine in the People’s Republic of China. The company offers seven varieties of approved traditional Chinese herbal medicines comprising four prescription drugs and three over the counter products in six delivery systems, including tablets, granules, capsules, formulations, concentrated powder, and medicinal wine for addressing rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues, and respiratory diseases. Its products include Lung Nourishing syrup to moisten the lung and relieve coughs; Tongbi capsules to promote blood circulation and relieve swelling and pain; Tongbi tablets to regulate and fortify the blood promote blood circulation and relieve swelling pain; Zhuangyuan Shenhailong medicinal wine to promote kidney function; and BazhenYimu cream for menstruation conditioning. The company’s products also comprise Fangfengtongsheng granules to treat fever, headache, constipation, measles, and eczema; Zhengxintai capsules to improve kidney function and treat coronary artery disease and angina. It sells its products through hospitals, local pharmacies, and retail drug store chains. The company is headquartered in Yantai, China.

827 Employees
Last Reported Date: 09/27/13

bohai pharmaceuticals group (BOPH) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $69.3K
Compensation as of Fiscal Year 2013.

bohai pharmaceuticals group (BOPH) Key Developments

Bohai Pharmaceuticals Group, Inc. Provides Preliminary Financial Guidance for the Third Quarter Ended March 31, 2014

Bohai Pharmaceuticals Group, Inc. provided preliminary financial guidance for the third quarter ended March 31, 2014. The company's estimated total revenue and net income for the third quarter of 2014 are proximately $35 million and $3.4 million as compared to $34.8 million and $3.2 million for the same period for the fiscal year 2013. The company currently produces seven traditional Chinese medicine products in China, among which two are on the State Essential Drugs List (the EDL), one is on the Provincial Essential Drugs list, five are on the National Drugs Reimbursement List, five have the Exclusive Drugs status, and two have the State Protected Chinese Medicine Status.

Bohai Pharmaceuticals Group, Inc. Announces Earnings Results for the Year Ended June 30, 2013

Bohai Pharmaceuticals Group, Inc. announced earnings results for the year ended June 30, 2013. For the year, the company net income of $19.12 million, or $0.91 per diluted share, for the year ended June 30, 2013, compared to $9.65 million, or $0.54 per diluted share, for the year ended June 30, 2012. Net revenues for the year ended June 30, 2013 were $151.79 million, compared to $137.37 million for the year ended June 30, 2012. Income from operations for the year ended June 30, 2013 was $26.88 million, compared to $28.37 million for the year ended June 30, 2012.

Ning Tang Resigns as Vice President of Production of Bohai Pharmaceuticals Group, Inc

Ning Tang notified the Bohai Pharmaceuticals Group, Inc. his resignation as the company's Vice President of Production, effective July 01, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOPH:US $1.02 USD 0.00

BOPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOPH.
View Industry Companies

Industry Analysis


Industry Average

Valuation BOPH Industry Range
Price/Earnings 1.0x
Price/Sales 0.1x
Price/Book 0.1x
Price/Cash Flow 0.8x
TEV/Sales NM Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOHAI PHARMACEUTICALS GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at